0001683168-18-001648.txt : 20180611 0001683168-18-001648.hdr.sgml : 20180611 20180611145017 ACCESSION NUMBER: 0001683168-18-001648 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180607 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 18891739 BUSINESS ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 8-K 1 radnet_8k-061118.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 7, 2018

 

 

 

RadNet, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 001-33307 13-3326724
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)

 

1510 Cotner Avenue

Los Angeles, California 90025

(Address of Principal Executive Offices) (Zip Code)

 

(310) 445-2800

(Registrant’s Telephone Number, Including Area Code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

  

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

At the Company’s Annual Meeting of Stockholders held on June 7, 2018, the stockholders considered and approved three proposals, each of which is described in more detail in the Company’s 2018 definitive proxy statement filed with the Securities and Exchange Commission on April 27, 2018 for the Annual Meeting of Stockholders.

 

The results detailed below represent the final voting results as certified by the Inspector of Elections:

 

Proposal 1

 

The stockholders elected the following seven directors to hold office until the 2019 Annual Meeting of Stockholders or until their successors are duly elected and qualified based on the following votes:

 

Director  For  Withheld  Broker Non-Votes
Howard G. Berger, M.D.  23,936,744  1,394,124  10,779,526
Marvin S. Cadwell  14,089,491  11,241,377  10,779,526
John V. Crues, III, M.D.  22,866,379  2,464,489  10,779,526
Norman R. Hames  23,598,592  1,732,276  10,779,526
Lawrence L. Levitt  14,072,934  11,257,934  10,779,526
Michael L. Sherman, M.D.  22,997,661  2,333,207  10,779,526
David L. Swartz  13,290,430  12,040,438  10,779,526

 

Proposal 2

 

The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018 was approved based on the following votes:

 

  For   Against   Abstentions
  35,860,310   238,085   11,999

 

Proposal 3

 

The non-binding advisory vote to approve the compensation of the Company’s named executive officers disclosed in the Company’s 2018 definitive proxy statement was approved based on the following votes:

 

For   Against   Abstentions   Broker Non-Votes
24,243,414   800,710   286,744   10,779,526

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 11, 2018 RadNet, Inc.
     
  By: /s/ Jeffrey L. Linden
  Name: Jeffrey L. Linden
  Title: Executive Vice President and General Counsel

 

 

 

 

 3